TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue152152152152.381
Cost of Revenue----
Gross Profit152152152152.381
Operating Expenses
Research Development159,391102,53369,23247,707.223
Selling General and Administrative15,16116,3319,88915,625.174
Non Recurring----
Others----
Total Operating Expenses174,552118,86479,12163,332.397
Operating Income or Loss-174,400-118,712-78,969-63,180.016
Income from Continuing Operations
Total Other Income/Expenses Net918236716231.37
Earnings Before Interest and Taxes-174,400-118,712-78,969-63,180.016
Interest Expense----
Income Before Tax-173,482-118,476-78,253-62,948.646
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-173,482-118,476-78,253-62,948.646
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-173,482-118,476-78,253-62,948.646
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-173,482-118,476-78,253-62,948.646